CEO SUMMARY: Each year, over 100 million new prescriptions are written for two classes of drugs with metabolic pathways affected by genetic variations in cytochrome P450. There are strong clinical arguments in favor of testing individuals for these genetic mutations to determine whether they are no, slow, or ultra-fast metabolizers of these drugs, before writing […]
CYP450 Plays Major Role In Drug Metabolization
Potential for CYP450 testing to be done in support of tens of millions of prescriptions
- By Robert Michel
- > From the Volume XIII No. 5 - April 10, 2006 Issue
- Tags: aco, arup lab, arup laboratories, cap, dna sequence, executive war college, genomic testing, genomics, hie, impac, in vitro diagnostic, in vitro diagnostics, laboratories, laboratory industry, laboratory test, laboratory testing, molecular diagnostic, pharmacogenomic tests, pharmacogenomics, roche diagnostic, roche diagnostics, the laboratory
